Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma

PURPOSE: Although we have shown the clinical benefit of bevacizumab (BEV) in the treatment of unresectable newly diagnosed glioblastomas (nd-GBM), the relationship between early radiographic response and survival outcome remains unclear. We performed a volumetric study of early radiographic response...

Descripción completa

Detalles Bibliográficos
Autores principales: Takigawa, Kosuke, Hata, Nobuhiro, Michiwaki, Yuhei, Hiwatashi, Akio, Yonezawa, Hajime, Kuga, Daisuke, Hatae, Ryusuke, Sangatsuda, Yuhei, Fujioka, Yutaka, Funakoshi, Yusuke, Otsuji, Ryosuke, Sako, Aki, Togao, Osamu, Yoshiura, Takashi, Yoshimoto, Koji, Mizoguchi, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437873/
https://www.ncbi.nlm.nih.gov/pubmed/34322829
http://dx.doi.org/10.1007/s11060-021-03812-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437873/
https://www.ncbi.nlm.nih.gov/pubmed/34322829
http://dx.doi.org/10.1007/s11060-021-03812-9

Ejemplares similares